Literature DB >> 24403911

ALTERED BLOOD SPHINGOLIPIDOMICS AND ELEVATED PLASMA INFLAMMATORY CYTOKINES IN COMBAT VETERANS WITH POST-TRAUMATIC STRESS DISORDER.

Samar M Hammad1, Jean-Philip Truman1, Mohammed M Al Gadban1, Kent J Smith1, Waleed O Twal1, Mark B Hamner2.   

Abstract

Patients with post-traumatic stress disorder (PTSD) have greater risk of developing cardiovascular disease (CVD). While chronically elevated plasma cholesterol and pro-inflammatory cytokines levels increase CVD risk, several studies have shown that cholesterol reduction does not reduce CVD risk. Acid sphingomyelinase (ASMase) activation has been implicated in both CVD and major depressive disorder. We investigated plasma pro-inflammatory cytokine levels, ASMase activity, and changes in sphingolipids in PTSD patients compared to healthy controls. Levels of interleukin 6, interleukin 10, interferon-γ and tumor necrosis factor-α were higher in PTSD patients than controls. Plasma ASMase activity and sphingosine 1-phosphate were higher in the PTSD group (1.6-fold and 2-fold, respectively; p<0.05). The results suggest that CVD risk factors in PTSD patients remain high despite cholesterol reduction.

Entities:  

Year:  2012        PMID: 24403911      PMCID: PMC3882130     

Source DB:  PubMed          Journal:  Neurobiol Lipids        ISSN: 1683-5506


  31 in total

1.  Statins and risk of coronary heart disease

Authors: 
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

Review 2.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Authors:  Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-05-12       Impact factor: 5.067

3.  Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.

Authors:  John F Thompson; Craig L Hyde; Linda S Wood; Sara A Paciga; David A Hinds; David R Cox; G Kees Hovingh; John J P Kastelein
Journal:  Circ Cardiovasc Genet       Date:  2009-02-12

4.  Diagnostic and statistical manual of mental disorders, 3rd ed. (DSM-III), adaptive functioning in young Swedish suicides.

Authors:  B S Runeson; C L Rich
Journal:  Ann Clin Psychiatry       Date:  1994-09       Impact factor: 1.567

5.  Cholesterol depletion attenuates tonic release but increases the ambient level of glutamate in rat brain synaptosomes.

Authors:  Tatiana Borisova; Natalia Krisanova; Roman Sivko; Arseniy Borysov
Journal:  Neurochem Int       Date:  2009-12-16       Impact factor: 3.921

Review 6.  Secretory sphingomyelinase.

Authors:  I Tabas
Journal:  Chem Phys Lipids       Date:  1999-11       Impact factor: 3.329

Review 7.  The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

Authors:  Jean-Charles Fruchart; Frank M Sacks; Michel P Hermans; Gerd Assmann; W Virgil Brown; Richard Ceska; M John Chapman; Paul M Dodson; Paola Fioretto; Henry N Ginsberg; Takashi Kadowaki; Jean-Marc Lablanche; Nikolaus Marx; Jorge Plutzky; Zeljko Reiner; Robert S Rosenson; Bart Staels; Jane K Stock; Rody Sy; Christoph Wanner; Alberto Zambon; Paul Zimmet
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

8.  Pharmacogenetic study of statin therapy and cholesterol reduction.

Authors:  Daniel I Chasman; David Posada; Lakshman Subrahmanyan; Nancy R Cook; Vincent P Stanton; Paul M Ridker
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

9.  Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.

Authors:  Joel A Simon; Feng Lin; Stephen B Hulley; Patricia J Blanche; David Waters; Stephen Shiboski; Jerome I Rotter; Deborah A Nickerson; Huiying Yang; Mohammed Saad; Ronald M Krauss
Journal:  Am J Cardiol       Date:  2006-01-27       Impact factor: 2.778

10.  Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells.

Authors:  Samar M Hammad; Tarek A Taha; Alena Nareika; Korey R Johnson; Maria F Lopes-Virella; Lina M Obeid
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-01-31       Impact factor: 3.072

View more
  10 in total

Review 1.  Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature.

Authors:  James B Lohr; Barton W Palmer; Carolyn A Eidt; Smitha Aailaboyina; Brent T Mausbach; Owen M Wolkowitz; Steven R Thorp; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-07       Impact factor: 4.105

2.  Plasma sphingolipids and depressive symptoms in coronary artery disease.

Authors:  Adam Dinoff; Mahwesh Saleem; Nathan Herrmann; Michelle M Mielke; Paul I Oh; Swarajya Lakshmi Vattem Venkata; Norman J Haughey; Krista L Lanctôt
Journal:  Brain Behav       Date:  2017-09-26       Impact factor: 2.708

3.  Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression.

Authors:  Christiane Mühle; Claudia Johanna Wagner; Katharina Färber; Tanja Richter-Schmidinger; Erich Gulbins; Bernd Lenz; Johannes Kornhuber
Journal:  J Clin Med       Date:  2019-06-13       Impact factor: 4.241

Review 4.  Inflammation in Post-Traumatic Stress Disorder (PTSD): A Review of Potential Correlates of PTSD with a Neurological Perspective.

Authors:  Tammy D Kim; Suji Lee; Sujung Yoon
Journal:  Antioxidants (Basel)       Date:  2020-01-26

5.  Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders.

Authors:  Pei-Fen Kuan; Xiaohua Yang; Roman Kotov; Sean Clouston; Evelyn Bromet; Benjamin J Luft
Journal:  Transl Psychiatry       Date:  2022-04-28       Impact factor: 7.989

6.  Repeated cocaine exposure prior to fear conditioning induces persistency of PTSD-like symptoms and enhancement of hippocampal and amygdala cell density in male rats.

Authors:  Asmae Lguensat; Christian Montanari; Cassandre Vielle; Mohamed Bennis; Saadia Ba-M'hamed; Christelle Baunez; René Garcia
Journal:  Brain Struct Funct       Date:  2021-06-30       Impact factor: 3.270

7.  Decreased AGO2 and DCR1 in PBMCs from War Veterans with PTSD leads to diminished miRNA resulting in elevated inflammation.

Authors:  M Bam; X Yang; E E Zumbrun; J P Ginsberg; Q Leyden; J Zhang; P S Nagarkatti; M Nagarkatti
Journal:  Transl Psychiatry       Date:  2017-08-29       Impact factor: 6.222

8.  Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.

Authors:  Samar M Hammad; Jasmyn R Hardin; Dulaney A Wilson; Waleed O Twal; Paul J Nietert; James C Oates
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

9.  Acid Sphingomyelinase Is a Modulator of Contextual Fear.

Authors:  Iulia Zoicas; Johannes Kornhuber
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

10.  Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value.

Authors:  Samar M Hammad; Olivia C Harden; Dulaney A Wilson; Waleed O Twal; Paul J Nietert; Jim C Oates
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.